Greater Cannabis Company, INC 10-Q quarterly reports

Trafalgar International, Inc. filed its Q2 2026 10-Q, revealing a net income of $578,002 for the six months ended June 30, 2026, but also highlighting substantial going concern risks and a strategic pivot.

The Greater Cannabis Company, Inc. filed its Q1 2026 10-Q, reporting a net loss of $33,376 and minimal cash, while detailing its strategic shift towards cannabinoid therapeutics and ongoing clinical trial preparations.

The Greater Cannabis Company reported a significant increase in net loss for the nine months ended September 30, 2025, alongside a reverse stock split and a new preferred stock issuance granting its CEO voting control.

The Greater Cannabis Company reported a significantly increased net loss and substantial dilution for Q2 2025, raising substantial doubt about its ability to continue as a going concern.

The Greater Cannabis Company, Inc. restated its Q1 2025 financial results to include significant note default penalties and interest, exacerbating its net loss and highlighting ongoing liquidity challenges.

The Greater Cannabis Company reported no revenue and an increased net loss for the quarter ended March 31, 2025, while continuing to focus on cannabinoid therapeutic development.

The Greater Cannabis Company reported no revenue and a net loss for the third quarter of 2024, while continuing to focus on the development of cannabinoid therapeutics.

The Greater Cannabis Company reported no revenue and a net loss of $89,528 for the six months ended June 30, 2024, while continuing to address going concern issues.

The Greater Cannabis Company reported no revenue and a net loss of $44,611 for the first quarter of 2024, with ongoing concerns about its ability to continue as a going concern.